FORTEA ORMAECHEA, JUAN FGS
jfortea@santpau.cat
Abdelnour Ruiz, Carla Sonsireec CIBER
Alcolea Rodriguez, Daniel Andres FGS
Alvarez Sanchez, Esther IR
Arranz Martinez, Javier FGS
Aumatell Escabias, Joaquim IR
Barroeta Espar, Isabel FGS
Bejanin, Alexandre Pierre Armand IR
Belvis Nieto, Robert FGS
Benitez Amaro, Aleyda IR
Bueno Lopez, Ana CIBER
Carmona Iragui, Maria FGS
Clos Batet, Susana IR
Del Hoyo Soriano, Laura IR
Dols Icardo, Oriol IR
Farre Maduell, Ariadna IR
Filella Merce, Julia IR
Flores Ramirez, Maria IR
Franquesa Mullerat, Maria IR
Gallardo Rubiales, Berta CIBER
Garcia Castro, Jesus IR
Garcia Hernandez, Estefania IR
Gimenez Badia, Sandra FGS
Illan Gala, Ignacio FGS
Lleo Bisa, Alberto FGS
Lorente Gordillo, Oriol IR
Maure Blesa, Lucia IR
Morcillo Nieto, Alejandra Omaira IR
Mota Rodriguez, Cecilia IR
Muñoz Llahuna, Laia IR
Padilla Franco, Concepcion UOC
Palmieri, Marisa Alejandra IR
Pertierra, Lucia IR
Reyes Santiago, Daniel CIBER
Ribosa Nogue, Roser IR
Rodriguez Baz, Iñigo IR
Rozalem Aranha, Mateus IR
Rubio Guerra, Sara FGS
Sala Matavera, Isabel FGS
Sanchez Aced, Erika IR
Sanchez Lopez, Oriol CIBER
Sanchez Saudinos, Maria Belen IR
Sanjuan Hernandez, Aida IR
Santos Santos, Miguel Angel FGS
Selma Gonzalez, Judit IR
Sirisi Dolcet, Sonia IR
Torres Alcala, Soraya IR
Valldeneu Castells, Silvia IR
Valle Tamayo, Natalia IR
Vaque Alcazar, Lidia IR
Vera Campuzano, Elena IR
Videla Toro, Laura IR
Zsadanyi, Sara Erzsebet UAB
Zhu, Nuole FGS
(JIF 2024)
-Abellaneda-Pérez K, Delgado-Martínez I, Salgado P, Ginés JM, Guardiola R, Vaqué-Alcázar L, Roca-Ventura A, Molist-Puigdomènech R, Manero RM, Viles-Garcia M, Medrano-Martorell S, Bartrés-Faz D, Pascual-Leone A, Pérez-Solà V, Villalba-Martínez G.Structural connectivity modifications following deep brain stimulation of the subcallosal cingulate and nucleus accumbens in severe anorexia nervosa. Acta Neurochirurgica. 2024; 166(1):364. DOI:10.1007/s00701-024-06258-w. PMID:39261306. IF:1,900 (Q2/4D). Document type: Article.
-Aldecoa I, Barroeta I, Carroll SL, Fortea J, Gilmore A, Ginsberg SD, Guzman SJ, Hamlett ED, Head E, Perez SE, Potter H, Molina-Porcel L, Raha-Chowdhury R, Wisniewski T, Yong WH, Zaman S, Ghosh S, Mufson EJ, Granholm AC.-Down Syndrome Biobank Consortium: A perspective.- Alzheimers Dement. 2024; 20(3):2262-2272. DOI:10.1002/alz.13692. PMID:38270275. IF:11,100 (Q1/1D). Document type: Article.
-Aranha MR, Montal V, van den Brink H, Pegueroles J, Carmona M, Videla L, Blesa LM, Benejam B, Arranz J, Valldeneu S, Barroeta I, Fernández S, Ribas L, Alcolea D, González S, Bargalló N, Biessels GJ, Blesa R, Lleó A, Coutinho AM, Leite CC, Bejanin A, Fortea J. Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRI. Alzheimers & Dementia. 2024; 20(6). DOI:10.1002/alz.13797. PMID:38644660. IF:11,100 (Q1/1D). Document type: Article.
-Arranz J, Zhu NL, Rubio S, Rodríguez I, Ferrer R, Carmona M, Barroeta I, Illan I, Santos M, Fortea J, Lleó A, Tondo M, Alcolea D. Diagnostic performance of plasma pTau217, pTau181, Aß1-42 and Aß1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alzheimers Research & Therapy. 2024; 16(1):139. DOI:10.1186/s13195-024-01513-9. PMID:38926773. IF:7,600 (Q1/1D). Document type: Article.
-Ashton NJ, Brum WS, Di G, Benedet AL, Arslan B, Jonaitis E, Langhough RE, Cody K, Wilson R, Carlsson CM, Vanmechelen E, Montoliu L, Lantero J, Rahmouni N, Tissot C, Stevenson J, Servaes S, Therriault J, Pascoal T, Lleó A, Alcolea D, Fortea J, Rosa P, Johnson S, Jeromin A, Blennow K, Zetterberg H. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurology. 2024; 81(3). DOI:10.1001/jamaneurol.2023.5319. PMID:38252443. IF:21,300 (Q1/1D). Document type: Article.
-Badhwar A, Hirschberg Y, Valle N, Iulita MF, Udeh CT, Matton A, Tarawneh RM, Rissman RA, Ledreux A, Winston CN, Haqqani AS, Alzheimers Assoc Int Soc A. Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview. Alzheimers & Dementia. 2024; 20(7). DOI:10.1002/alz.13823. PMID:38864416. IF:11,100 (Q1/1D). Document type: Article.
-Belvís R, Irimia P, González N, García J, Pozo P, López A, Morollón N, Quintas S, Plana A, Baz PG, Tentor A, Artiles NG, León FJ, Martín MP, Rivera I, Ramírez R, Colomina I, Lainez JM, Pascual J. Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment. MEDICINA CLINICA. 2024; 163(4). DOI:10.1016/j.medcli.2024.02.006. PMID:38643025. IF:2,100 (Q2/3D). Document type: Article.
-Caillaud M, Laisney M, Bejanin A, Duclos H, Scherer-Gagou C, Prundean A, Bonneau D, Eustache F, Verny C, Desgranges B, Allain P. Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimaging. J Huntingtons Dis. 2024; 13(4):467-477. DOI:10.1177/18796397241291730. PMID:39973378. IF:3,100 (Q2/5D). Document type: Article.
-Cano A, Capdevila M, Puerta R, Arranz J, Montrreal L, de Rojas I, García P, Olivé C, García F, Sotolongo O, Orellana A, Aguilera N, Ramis M, Rosende M, Lleó A, Fortea J, Tartari JP, Lafuente A, Vargas L, Pérez A, Muñoz N, Sanabria A, Alegret M, Morató X, Tárraga L, Fernández V, Marquié M, Valero S, Alcolea D, Boada M, Ruiz A. Clinical value of plasma pTau181 to predict Alzheimer’s ‘ s disease pathology in a large real-world cohort of a memory clinic. EBioMedicine. 2024; 108:105345. DOI:10.1016/j.ebiom.2024.105345. PMID:39299003. IF:10,800 (Q1/1D). Document type: Article.
-Carbayo A, Borrego S, Turon J, Cortés E, Molina L, Gascón J, Rubio MA, Povedano M, Gámez J, Sotoca J, Juntas R, Almendrote M, Marquié M, Sánchez R, Illán I, Dols O, Rubio S, Bernal S, Caballero M, Vesperinas A, Gelpi E, Rojas R. Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum. BRAIN. 2024; 147(7). DOI:10.1093/brain/awae011. PMID:38227807. IF:11,700 (Q1/1D). Document type: Article.
-Carmona M, ‘Connor AO, Llibre J, Lao PT, Ashton NJ, Fortea J, Sánchez R. Clinical and research application of fluid bio markers in autosomal dominant Alzheimer’s disease and Down syndrome. EBioMedicine. 2024; 108:105327. DOI:10.1016/j.ebiom.2024.105327. PMID:39366843. IF:10,800 (Q1/1D). Document type: Article.
-Chatterjee M, Özdemir S, Fritz C, Möbius W, Kleineidam L, Mandelkow E, Biernat J, Dogdu C, Peters O, Cosma NC, Wang X, Schneider LS, Priller J, Spruth E, Kühn AA, Krause P, Klockgether T, Vogt IR, Kimmich O, Spottke A, Hoffmann DC, Fliessbach K, Miklitz C, McCormick C, Weydt P, Falkenburger B, Brandt M, Guenther R, Dinter E, Wiltfang J, Hansen N, Bähr M, Zerr I, Flöel A, Nestor PJ, Düzel E, Glanz W, Incesoy E, Bürger K, Janowitz D, Perneczky R, Rauchmann BS, Hopfner F, Wagemann O, Levin J, Teipel S, Kilimann I, Goerss D, Prudlo J, Gasser T, Brockmann K, Mengel D, Zimmermann M, Synofzik M, Wilke C, Selma J, Turon J, Santos MA, Alcolea D, Rubio S, Fortea J, Carbayo A, Lleó A, Rojas R, Illán I, Wagner M, Frommann I, Roeske S, Bertram L, Heneka MT, Brosseron F, Ramirez A, Schmid M, Beschorner R, Halle A, Herms J, Neumann M, Barthélemy NR, Bateman RJ, Rizzu P, Heutink P, Dols O, Höglinger G, Hermann A, Schneider A. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. NATURE MEDICINE. 2024; 30(6). DOI:10.1038/s41591-024-02937-4. PMID:38890531. IF:50,000 (Q1/1D). Document type: Article.
-Chia R, Ray A, Shah Z, Ding J, Ruffo P, Fujita M, Menon V, Saez S, Reho P, Kaivola K, Walton RL, Reynolds RH, Karra R, Sait S, Akcimen F, Diez M, Alvarez I, Fanciulli A, Stefanova N, Seppi K, Duerr S, Leys F, Krismer F, Sidoroff V, Zimprich A, Pirker W, Rascol O, Foubert A, Meissner WG, Tison F, Pavy A, Pellecchia MT, Barone P, Russillo MC, Marín J, Kulisevsky J, Torres S, Mir P, Periñán MT, Proukakis C, Chelban V, Wu L, Goh YY, Parkkinen L, Hu MT, Kobylecki C, Saxon JA, Rollinson S, Garland E, Biaggioni I, Litvan I, Rubio I, Alcalay RN, Kwei KT, Lubbe SJ, Mao QW, Flanagan ME, Castellani RJ, Khurana V, Ndayisaba A, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Moore A, Norcliffe L, Palma JA, Kaufmann H, Kim C, Iba M, Masliah E, Dawson TM, Rosenthal LS, Pantelyat A, Albert MS, Pletnikova O, Troncoso JC, Infante J, Lage C, Sánchez P, Serrano GE, Beach TG, Pastor P, Morris HR, Albani D, Clarimon J, Wenning GK, Hardy JA, Ryten M, Topol E, Torkamani A, Chio A, Bennett DA, De Jager PL, Low PA, Singer W, Cheshire WP, Wszolek ZK, Dickson DW, Traynor BJ, Gibbs JR, Dalgard CL, Ross OA, Houlden H, Scholz SW. Genome sequence analyses identify novel risk loci for multiple system atrophy. NEURON. 2024; 112(13). DOI:10.1016/j.neuron.2024.04.002. PMID:38701790. IF:15,000 (Q1/1D). Document type: Article.
-de Dios A, Pages N, Ojeda S, Riera P, Pelegrin R, Morollon N, Belvis R, Real J, Masip M. Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine. HEADACHE. 2024; DOI:10.1111/head.14827. PMID:39268992. IF:4,000 (Q1/2D). Document type: Article.
-del Rincón CR, Gonzalez A, Quintas S, García D, Lázaro IF, Guerrero AL, Osorio YG, Santos S, Oria CG, Rodríguez NS, Díez FI, Iñiguez AE, Luque SG, Huerta M, Díaz SC, Muñoz A, Ros AL, Sánchez A, Juanes FV, Kortazar I, Echeverria A, Rodríguez J, Sánchez AJ, Garcia AG, Sánchez NM, Belvis R, Pérez MPN, García JC, Escudero M, Montes N, Gago AB. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(4). DOI:10.1111/ene.16203. PMID:38270379. IF:3,900 (Q1/3D). Document type: Article.
-Dols O, Carbayo A, Jericó I, Blasco O, Alvarez E, Pérez M, Bernal S, Rodríguez B, Cusco I, Turon J, Cabezas M, Caballero M, Vesperinas A, Llansó L, Pagola I, Torné L, Valle N, Muñoz L, Rubio S, Illán I, Cortés E, Gelpi E, Rojas R. Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024; DOI:10.1136/jnnp-2024-333834. PMID:38960585. IF:7,500 (Q1/1D). Document type: Article.
-Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D, Kivipelto M, Jessen F, Hanseeuw B, Boada M, Barkhof F, Nordberg A, Froelich L, Waldemar G, Frederiksen KS, Padovani A, Planche V, Rowe C, Bejanin A, Ibanez A, Cappa S, Caramelli P, Nitrini R, Allegri R, Slachevsky A, de Souza LC, Bozoki A, Widera E, Blennow K, Ritchie C, Agronin M, Lopera F, Delano L, Bombois S, Levy R, Thambisetty M, Georges J, Jones DT, Lavretsky H, Schott J, Gatchel J, Swantek S, Newhouse P, Feldman HH, Frisoni GB. Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation. JAMA Neurology. 2024; 81(12). DOI:10.1001/jamaneurol.2024.3770. PMID:39483064. IF:21,300 (Q1/1D). Document type: Review.
-Fortea J, Pegueroles J, Alcolea D, Belbin O, Dols O, Vaqué L, Videla L, Gispert JD, Suárez M, Johnson SC, Sperling R, Bejanin A, Lleó A, Montal V. APOE4 homozygozity represents a distinct genetic form of Alzheimer’s disease. NATURE MEDICINE. 2024; DOI:10.1038/s41591-024-02931-w. PMID:38710950. IF:50,000 (Q1/1D). Document type: Article.
-García D, Martínez C, Muñiz JC, Gago AB, Sánchez NM, González V, Porta J, Sierra A, Gonzalez N, González Y, Polanco M, Recio A, Nieto RB, Guerrero AL. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine. CEPHALALGIA. 2024; 44(4):03331024241248833. DOI:10.1177/03331024241248833. PMID:38663908. IF:4,600 (Q1/2D). Document type: Article.
-Gómez S, Becerra F, Sendra E, Zamorano L, Grau I, Pintado V, Padilla B, Benito N, Boix L, Fariñas MC, Peñaranda M, Gamallo MR, Martinez JA, Morte E, Del Pozo JL, Montesinos IL, Durán X, Ponz R, Cotarelo M, Cantón R, Oliver A, Ruiz P, Horcajada JP, TUBRAS 2GRP. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain. JOURNAL OF HOSPITAL INFECTION. 2024; 151DOI:10.1016/j.jhin.2024.05.020. PMID:38945399. IF:3,100 (Q1/3D). Document type: Article.
-Gómez-Pascual A, Naccache T, Xu J, Hooshmand K, Wretlind A, Gabrielli M, Lombardo MT, Shi L, Buckley NJ, Tijms BM, Vos SJB, Ten Kate M, Engelborghs S, Sleegers K, Frisoni GB, Wallin A, Lleó A, Popp J, Martinez-Lage P, Streffer J, Barkhof F, Zetterberg H, Visser PJ, Lovestone S, Bertram L, Nevado-Holgado AJ, Gualerzi A, Picciolini S, Proitsi P, Verderio C, Botía JA, Legido-Quigley C.Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer’s disease. Comput Biol Med. 2024; 176:108588. DOI:10.1016/j.compbiomed.2024.108588. PMID:38761503. IF:6,300 (Q1/1D). Document type: Article.
-Grunden N, Calabria M, García C, Pons C, Arroyo JA, Gómez B, Estévez MD, Belvís R, Morollón N, Cordero M, Mur I, Pomar V, Domingo P. Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints. PLoS One. 2024; 19(8):e0302415. DOI:10.1371/journal.pone.0302415. PMID:39116061. IF:2,600 (Q2/4D). Document type: Article.
-Hillerstrom H, Fisher R, Janicki MP, Chicoine B, Christian BT, Esbensen A, Esralew L, Fortea J, Hartley S, Hassenstab J, Keller SM, Krinsky S, Lai FRC, Levin J, Mccarron M, Mcdade E, Rebillat AS, Rosas HD, Silverman W, Strydom A, Zaman SH, Zetterberg H. Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome. Alzheimers & Dementia. 2024; 20(5). DOI:10.1002/alz.13778. PMID:38480678. IF:11,100 (Q1/1D). Document type: Article.
-Jacobs T, Jacobson SR, Fortea J, Berger JS, Vedvyas A, Marsh K, He TS, Gutierrez E, Fillmore NR, Gonzalez M, Figueredo L, Gaggi NL, Plaska CR, Pomara N, Blessing E, Betensky R, Rusinek H, Zetterberg H, Blennow K, Glodzik L, Wisniweski TM, de Leon MJ, Osorio RS, Ramos J, Alzheimers N. The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity & Ageing. 2024; 21(1):32. DOI:10.1186/s12979-024-00435-2. PMID:38760856. IF:5,600 (Q1/2D). Document type: Article.
-Jensen AMG, Raska J, Fojtik P, Monti G, Lunding M, Bartova S, Pospisilova V, van der Lee SJ, Van Dongen J, Bossaerts L, Van Broeckhoven C, Dols-Icardo O, Lléo A, Bellini S, Ghidoni R, Hulsman M, Petsko GA, Sleegers K, Bohaciakova D, Holstege H, Andersen OM.The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer’s disease.Proc Natl Acad Sci U S A. 2024; 121(37):e2408262121. DOI:10.1073/pnas.2408262121. PMID:39226352. IF:9,100 (Q1/2D). Document type: Article.
-Koetsier J, Cavill R, Reijnders R, Harvey J, Homann J, Kouhsar M, Deckers K, Kohler S, Eijssen LMT, van den Hove D, Demuth I, Düzel S, Smith RG, Smith AR, Burrage J, Walker EM, Shireby G, Hannon E, Dempster E, Frayling T, Mill J, Dobricic V, Johannsen P, Wittig M, Franke A, Vandenberghe R, Schaeverbeke J, Freund Y, Frölich L, Scheltens P, Teunissen CE, Frisoni G, Blin O, Richardson JC, Bordet R, Engelborghs S, de Roeck E, Martinez P, Tainta M, Lleó A, Sala I, Popp J, Peyratout G, Verhey F, Tsolaki M, Andreasson U, Blennow K, Zetterberg H, Streffer J, Vos SJB, Lovestone S, Visser PJ, Lill CM, Bertram L, Lunnon K, Pishva E, Alzheimers Disease Neuroimaging I. Blood-based multivariate methylation risk score for cognitive impairment and dementia. Alzheimers & Dementia. 2024; 20(10). DOI:10.1002/alz.14061. PMID:39193899. IF:11,100 (Q1/1D). Document type: Article.
-Larsen FK, Baksh RA, Mcglinchey E, Langballe EM, Benejam B, Beresford J, Mccarron M, Coppus A, Falquero S, Fortea J, Levin J, Loosli SV, Mark R, Rebillat AS, Zaman S, Strydom A. Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium. Alzheimers & Dementia. 2024; 20(5). DOI:10.1002/alz.13779. PMID:38506627. IF:11,100 (Q1/1D). Document type: Article.
-Lorca-Puls DL, Gajardo-Vidal A, Mandelli ML, Illán-Gala I, Ezzes Z, Wauters LD, Battistella G, Bogley R, Ratnasiri B, Licata AE, Battista P, García AM, Tee BL, Lukic S, Boxer AL, Rosen HJ, Seeley WW, Grinberg LT, Spina S, Miller BL, Miller ZA, Henry ML, Dronkers NF, Gorno-Tempini ML.Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum. Brain. 2024; 147(2):607-626. DOI:10.1093/brain/awad327. PMID:37769652. IF:11,700 (Q1/1D). Document type: Article.
-Manzoni C, Kia DA, Ferrari R, Leonenko G, Costa B, Saba V, Jabbari E, Tan MMX, Albani D, Alvarez V, Alvarez I, Andreassen OA, Angiolillo A, Arighi A, Baker M, Benussi L, Bessi V, Binetti G, Blackburn DJ, Boada M, Boeve BF, Borrego S, Borroni B, Bråthen G, Brooks WS, Bruni AC, Caroppo P, Bandres S, Clarimon J, Colao R, Cruchaga C, Danek A, de Boer SCM, de Rojas I, di A, Dickson DW, Diehl J, Dobson C, Dols O, Donizetti A, Dopper E, E, Ferrari C, Forloni G, Frangipane F, Fratiglioni L, Kramberger MG, Galimberti D, Gallucci M, García P, Ghidoni R, Giaccone G, Graff C, Graff NR, Grafman J, Halliday GM, Hernandez DG, Hjermind LE, Hodges JR, Holloway G, Huey ED, Illán I, Josephs KA, Knopman DS, Kristiansen M, Kwok JB, Leber I, Leonard HL, Libri I, Lleo A, Mackenzie IR, Madhan GK, Maletta R, Marquié M, Maver A, Menendez M, Milan G, Miller BL, Morris CM, Morris HR, Nacmias B, Newton J, Nielsen JE, Nilsson C, Novelli V, Padovani A, Pal S, Pasquier F, Pastor P, Perneczky R, Peterlin B, Petersen RC, Piguet O, Pijnenburg Y, Puca AA, Rademakers R, Rainero I, Reus LM, Richardson A, Riemenschneider M, Rogaeva E, Rogelj B, Rollinson S, Rosen H, Rossi G, Rowe JB, Rubino E, Ruiz A, Salvi E, Sanchez R, Sando SB, Santillo AF, Saxon JA, Schlachetzki JCM, Scholz SW, Seelaar H, Seeley WW, Serpente M, Sorbi S, Sordon S, St George P, Thompson JC, Van C, Van VM, Van der Lee SJ, Van J, Tagliavini F, van der Zee J, Veronesi A, Vitale E, Waldo ML, Yokoyama JS, Nalls MA, Momeni P, Singleton AB, Hardy J, Escott V. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia. AMERICAN JOURNAL OF HUMAN GENETICS. 2024; 111(7). DOI:10.1016/j.ajhg.2024.05.017. PMID:38889728. IF:8,100 (Q1/1D). Document type: Article.
-Mínguez A, López A, Quintas S, Nieves C, Layos A, Belvís R, Irimia P, Díaz S. New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants. REVISTA DE NEUROLOGIA. 2024; 78(2). DOI:10.33588/rn.7802.2023176. PMID:38223948. IF:0,800 (Q4/9D). Document type: Review.
-Morcillo AO, Zsadanyi SE, Arriola JE, Carmona M, Montal V, Pegueroles J, Aranha MR, Vaque L, Padilla C, Benejam B, Videla L, Barroeta I, Fernandez S, Altuna M, Gimenez S, Gonzalez S, Bargallo N, Ribas L, Arranz J, Torres S, Iulita MF, Belbin O, Camacho V, Alcolea D, Lleo A, Fortea J, Bejanin A. Characterization of white matter hyperintensities in Down syndrome. Alzheimers & Dementia. 2024; 20(9). DOI:10.1002/alz.14146. PMID:39087352. IF:11,100 (Q1/1D). Document type: Article.
-Mulet L, Solé C, Cabello M, Abellaneda K, Perellón R, Cattaneo G, Sánchez JS, Alviarez V, Bargalló N, Tormos JM, Pascual A, Bartrés D, Vaqué L. Impact of repetitive negative thinking on subjective cognitive decline: insights into cognition and brain structure. Frontiers in Aging Neuroscience. 2024; 16:1441359. DOI:10.3389/fnagi.2024.1441359. PMID:39193493. IF:4,500 (Q1/2D). Document type: Article.
-Navarro MP, González V, Muñoz A, Madrigal E, Alpuente A, Latorre G, Molina F, Monzón MJ, Medrano V, García D, González C, Gago A, Velasco F, Beltrán I, Morollón N, Viguera J, Casas J, Rodriguez J, Cuadrado E, Irimia P, Iglesias F, Guerrero ÁL, Belvís R, Pozo P, Pascual J, Santos S. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study. Frontiers in Neurology. 2024; 15:1417831. DOI:10.3389/fneur.2024.1417831. PMID:38938776. IF:2,800 (Q2/5D). Document type: Article.
Nuytemans K, Franzen S, Broce IJ, Caramelli P, Ellajosyula R, Finger E, Gupta V, Gupta V, Illan I, Loi SM, Morhardt D, Pijnenburg Y, Rascovsky K, Williams MM, Yokoyama JS, Acosta J, Akinyemi R, Alladi S, Ayele BA, Ayhan Y, Bourdage R, Castro S, de Souza LC, Dacks P, de Boer SCM, de Leon J, Dodge S, Grasso S, Ghoshal N, Kamath V, Kumfor F, Matias JA, Narme P, Nielsen TR, Okhuevbie D, Pina S, Ruiz R, Ryan B, Scarioni M, Slachevsky A, Suarez A, Tee BL, Tsoy E, Ulugut H, Onyike CU, Babulal GM. Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research. Alzheimers & Dementia. 2024; DOI:10.1002/alz.14312. PMID:39535468. IF:11,100 (Q1/1D). Document type: Article.
-Pané A, Videla L, Calvet A, Viaplana J, Vaqué L, Ibarzabal A, Rozalem M, Pegueroles J, Moize V, Vidal J, Ortega E, Barroeta I, Camacho V, Chiva G, Fortea J, Jiménez A. Hypothalamic Inflammation Improves Through Bariatric Surgery, and Hypothalamic Volume Predicts Short-Term Weight Loss Response in Adults With or Without Type 2 Diabetes. DIABETES CARE. 2024; 47(7). DOI:10.2337/dc23-2213. PMID:38713908. IF:16,600 (Q1/1D). Document type: Article.
-Pardo J, Montal V, Campabadal A, Oltra J, Uribe C, Roura I, Bargalló N, Martí MJ, Compta Y, Iranzo A, Fortea J, Junqué C, Segura B. Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder. MOVEMENT DISORDERS. 2024; 39(5). DOI:10.1002/mds.29761. PMID:38456361. IF:7,600 (Q1/1D). Document type: Article.
-Pascoal TA, Aguzzoli CS, Lussier FZ, Crivelli L, Suemoto CK, Fortea J, Rosa P, Zimmer ER, Ferreira PCL, Bellaver B. Insights into the use of biomarkers in clinical trials in Alzheimer’s ‘ s disease. EBioMedicine. 2024; 108:105322. DOI:10.1016/j.ebiom.2024.105322. PMID:39366844. IF:10,800 (Q1/1D). Document type: Review.
-Pasquini L, Pereira FL, Seddighi S, Zeng Y, Wei YB, Illán I, Vatsavayai SC, Friedberg A, Lee AJ, Brown JA, Spina S, Grinberg LT, Sirkis DW, Bonham LW, Yokoyama JS, Boxer AL, Kramer JH, Rosen HJ, Humphrey J, Gitler AD, Miller BL, Pollard KS, Ward ME, Seeley WW. Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes. BRAIN. 2024; 147(9). DOI:10.1093/brain/awae205. PMID:38940350. IF:11,700 (Q1/1D). Document type: Article.
-Petersen ME, Flores L, Head E, Montoliu L, Strydom A, Pape SE, Fortea J, Ashton NJ, Udeh C, O’Bryant SE, German D, Despa F, Mapstone M, Zetterberg H. Blood biomarkers in Down syndrome: Facilitating Alzheimer’s disease detection and monitoring. Alzheimers & Dementia. 2024; DOI:10.1002/alz.14364. PMID:39535517. IF:11,100 (Q1/1D). Document type: Article.
-Pitart C, Piquet M, Burgwinkel T, Del Pino RA, Rubio M, Aguilar M, De Gea S, Pulgarín A, Campo I, Torralbo B, Parejo R, Valls S, Fortes I, Santana G, Rubio E, Vilella A, Del Rio A, Martinez JA, Miró E, Navarro F, Espasa M, Casals C, Vila J, Higgins PG, Roca I. Early identification of the nosocomial spread of vancomycin-resistant Enterococcus faecium by Fourier-transform infrared spectroscopy and performance comparison with PFGE and WGS. Emerging Microbes & Infections. 2024; 13(1):2392659. DOI:10.1080/22221751.2024.2392659. PMID:39137261. IF:7,500 (Q1/1D). Document type: Article.
-Rubenstein E, Tewolde S, Michals A, Weuve J, Fortea J, Fox MP, Jimenez MP, Scott A, Tripodis Y, Skotko BG. Alzheimer Dementia Among Individuals With Down Syndrome. JAMA Network Open. 2024; 7(9):e2435018. DOI:10.1001/jamanetworkopen.2024.35018. PMID:39312235. IF:9,700 (Q1/1D). Document type: Article.
-Rubenstein E, Tewolde S, Skotko BG, Michals A, Fortea J. Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS. 2024; 196(4). DOI:10.1002/ajmg.c.32097. PMID:38925597. IF:4,400 (Q1/2D). Document type: Article.
-Schöll M, Verberk I, del Campo M, Delaby C, Therriault J, Chong JR, Palmqvist S, Alcolea D. Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease. Lancet Healthy Longevity. 2024; 5(10):100630. DOI:10.1016/j.lanhl.2024.07.013. PMID:39369727. IF:14,600 (Q1/1D). Document type: Article.
-Sierra A, Ribosa R, Vidal N, Aldecoa I, Turón E, Rodríguez B, Turón M, Boronat S, Molina L. Inherited SCN1A missense mutation in a Dravet Syndrome family: Neuropathological correlation, family screening and implications for adult carriers. EPILEPSY RESEARCH. 2024; 199:107266. DOI:10.1016/j.eplepsyres.2023.107266. PMID:38061235. IF:2,000 (Q3/7D). Document type: Article.
-Sirisi S, Sánchez E, Belbin O, Lleó A. APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets. Alzheimers Research & Therapy. 2024; 16(1):144. DOI:10.1186/s13195-024-01504-w. PMID:38951839. IF:7,600 (Q1/1D). Document type: Review.
-Smith RG, Pishva E, Kouhsar M, Imm J, Dobricic V, Johannsen P, Wittig M, Franke A, Vandenberghe R, Schaeverbeke J, Freund Y, Frölich L, Scheltens P, Teunissen CE, Frisoni G, Blin O, Richardson JC, Bordet R, Engelborghs S, de Roeck E, Martinez P, Altuna M, Tainta M, Lleó A, Sala I, Popp J, Peyratout G, Winchester L, Nevado A, Verhey F, Tsolaki M, Andreasson U, Blennow K, Zetterberg H, Streffer J, Vos SJB, Lovestone S, Visser PJ, Bertram L, Lunnon K. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF-AD study. Alzheimers & Dementia. 2024; 20(10). DOI:10.1002/alz.14098. PMID:39193893. IF:11,100 (Q1/1D). Document type: Article.
-Swift IJ, Rademakers R, Finch N, Baker M, Ghidoni R, Benussi L, Binetti G, Rossi G, Synofzik M, Wilke C, Mengel D, Graff C, Takada LT, Sanchez R, Antonell A, Galimberti D, Fenoglio C, Serpente M, Arcaro M, Schreiber S, Vielhaber S, Arndt P, Santana I, Almeida MR, Moreno F, Barandiaran M, Gabilondo A, Stubert J, Gomez E, Agueero P, Sainz MJ, Gohda T, Murakoshi M, Kamei N, Kittel S, Reif A, Weigl J, Jian JL, Liu CJ, Serrero G, Greither T, Theil G, Lohmann E, Gazzina S, Bagnoli S, Coppola G, Bruni A, Quante M, Kiess W, Hiemisch A, Jurkutat A, Block MS, Carlson AM, Bråthen G, Sando SB, Grontvedt GR, Lauridsen C, Heslegrave A, Heller C, Abel E, Gómez A, Puey R, Arighi A, Rotondo E, Jiskoot LC, Meeter LHH, Duraes J, Lima M, Tábuas M, Lemos J, Boeve B, Petersen RC, Dickson DW, Graff NR, Leber I, Sellami L, Lamari F, Clot F, Borroni B, Cantoni V, Rivolta J, Lleó A, Fortea J, Alcolea D, Illán I, Andres L, Van P, Clarimon J, Steinacker P, Feneberg E, Otto M, van der Ende EL, van JC, Seelaar H, Zetterberg H, Sogorb A, Rohrer JD. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors. Alzheimers Research & Therapy. 2024; 16(1):66. DOI:10.1186/s13195-024-01420-z. PMID:38539243. IF:7,600 (Q1/1D). Document type: Article.
-Therriault J, Janelidze S, Benedet AL, Ashton NJ, Martínez JA, Gonzalez A, Bellaver B, Alcolea D, Vrillon A, Karim H, Mielke MM, Hong CH, Roh HW, Contador J, Pijoan AP, Algeciras A, Vemuri P, Graff J, Lowe VJ, Karikari TK, Jonaitis E, Brum W, Tissot C, Servaes S, Rahmouni N, Macedo AC, Stevenson J, Fernandez J, Wang YT, Woo MS, Friese MA, Jia WL, Dumurgier J, Hourregue C, Cognat E, Ferreira PL, Vitali P, Johnson S, Pascoal TA, Gauthier S, Lleó A, Paquet C, Petersen RC, Salmon D, Mattsson N, Palmqvist S, Stomrud E, Galasko D, Son SJ, Zetterberg H, Fortea J, Suárez M, Jack CR, Blennow K, Hansson O, Rosa P. Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability. Nature Aging. 2024; 4(11). DOI:10.1038/s43587-024-00731-y. PMID:39533113. IF:19,400 (Q1/1D). Document type: Article.
-Ulugut H, Bertoux M, Younes K, Montembeault M, Fumagalli GG, Samanci B, Illan I, Kuchcinski G, Leroy M, Thompson JC, Kobylecki C, Santillo AF, Englund E, Waldö ML, Riedl L, van den Stock J, Vandenbulcke M, Vandenberghe R, Laforce RJR, Ducharme S, Pressman PS, Caramelli P, de Souza LC, Takada LT, Gurvit H, Hansson O, Diehl J, Galimberti D, Pasquier F, Miller BL, Scheltens P, Ossenkoppele R, van der Flier WM, Barkhof F, Fox NC, Sturm VE, Miyagawa T, Whitwell JL, Boeve B, Rohrer JD, Gorno ML, Josephs KA, Snowden J, Warren JD, Rankin KP, Pijnenburg Y, Int RTVFTDGRP. Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study. Alzheimers & Dementia. 2024; 20(8). DOI:10.1002/alz.14076. PMID:38982845. IF:11,100 (Q1/1D). Document type: Article.
-Verberk I, Jutte J, Kingma MY, Vigneswaran S, Gouda M, van MP, Alcolea D, Arranz J, Fortea J, Lleó A, Chevalier C, Marizzoni M, van de Giessen EM, Lemstra AW, Pijnenburg Y, van der Flier WM, den A, Wilson D, Schut MC, van AC, Teunissen CE. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice. Alzheimers & Dementia. 2024; 20(9). DOI:10.1002/alz.14088. PMID:39096164. IF:11,100 (Q1/1D). Document type: Article.
-Zsadanyi SE, Morcillo-Nieto AO, Aranha MR, Aragón I, Arriola-Infante JE, Vaqué-Alcázar L, Montal V, Pegueroles J, Arranz J, Rodríguez-Baz Í, Blesa LM, Videla L, Barroeta I, Del Hoyo Soriano L, Benejam B, Fernández S, Hernandez AS, Bargallo N, González-Ortiz S, Giménez S, Alcolea D, Belbin O, Lleó A, Fortea J, Carmona-Iragui M, Bejanin A. Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome. Neurology. 2024; 103(4):e209676. DOI:10.1212/WNL.0000000000209676. PMID:39074338. IF:8,500 (Q1/1D). Document type: Article.
(JIF 2023)
-Abellaneda K, Cattaneo G, Cabello M, Solana J, Mulet L, Vaque L, Perellon R, Sole C, Bargallo N, Tormos JM, Pascual A, Bartres D. Purpose in life promotes resilience to age-related brain burden in middle-aged adults. Alzheimers Research & Therapy. 2023; 15(1):49. DOI:10.1186/s13195-023-01198-6. PMID:36915148. IF:8,000 (Q1/1D). Document type: Article.
-Acha B, Corroza J, de Gordoa JSR, Cabello C, Robles M, Mendez I, Macías M, Zueco S, Roldan M, Urdánoz A, Jericó I, Erro ME, Alcolea D, Lleo A, Blanco I, Mendioroz M, iBEAS GRP. Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease. NEUROLOGY. 2023; 101(23). DOI:10.1212/WNL.0000000000207865. PMID:37827850. IF:8,400 (Q1/1D). Document type: Article.
-Alcolea D, Beeri MS, Rojas JC, Gardner RC, Lleo A. Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist. NEUROLOGY. 2023; 101(4). DOI:10.1212/WNL.0000000000207193. PMID:36878698. IF:8,400 (Q1/1D). Document type: Review.
-Álvarez R, Dols O, El Bounasri S, López L, Trujillo JC, Reyes D, Suárez X, Cortés E, Illa I, Gallardo E. Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2):e200085. DOI:10.1212/NXI.0000000000200085. PMID:36697230. IF:8,300 (Q1/1D). Document type: Article.
-Aranha MR, Coutinho AM, Carneiro CD, Pastorello BF, Studart A, Guariglia CC, Tsunemi MH, Moreira E, Ianof JN, Anghinah R, Nitrini R, Cerri GG, Fortea J, Buchpiguel CA, Leite CC. Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study. ARQUIVOS DE NEURO-PSIQUIATRIA. 2023; 81(05). DOI:10.1055/s-0043-1768666. PMID:37257463. IF:1,000 (Q4/8D). Document type: Article.
-Aranha MR, Iulita MF, Montal V, Pegueroles J, Bejanin A, Vaqué L, Grothe MJ, Carmona M, Videla L, Benejam B, Arranz J, Padilla C, Valldeneu S, Barroeta I, Altuna M, Fernández S, Ribas L, Valle N, Alcolea D, González S, Bargalló N, Zetterberg H, Blennow K, Blesa R, Wisniewski T, Busciglio J, Cuello AC, Lleó A, Fortea J. Basal forebrain atrophy along the Alzheimer’s disease continuum in adults with Down syndrome. Alzheimers & Dementia. 2023; 19(11). DOI:10.1002/alz.12999. PMID:37021589. IF:13,000 (Q1/1D). Document type: Article.
-Borrego S, Montagut N, Martín P, Vaqué L, Illán I, Balasa M, Lladó A, Casanova J, Bargalló N, Valls J, Lleó A, Bartrés D, Sánchez R. Multifocal Transcranial Direct Current Stimulation in Primary Progressive Aphasia Does Not Provide a Clinical Benefit Over Speech Therapy. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(3). DOI:10.3233/JAD-230069. PMID:37182884. IF:3,400 (Q2/4D). Document type: Article.
-Colom M, Davies C, Sirisi S, Lee J-E, Simzer EM, Tzioras M, Querol M, Sánchez É, Chang YY, Holt K, McGeachan RI, Rose J, Tulloch J, Wilkins L, Smith C, Andrian T, Belbin O, Pujals S, Horrocks MH, Lleó A, Spires TL. Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain. NEURON. 2023; 111(14):2170-2183.e6. DOI:10.1016/j.neuron.2023.04.020. PMID:37192625. IF:14,700 (Q1/1D). Document type: Article.
-de Luna N, Carbayo Á, Dols O, Turon J, Reyes D, Illan I, Jericó I, Pagola I, Lleixà C, Querol L, Rubio S, Alcolea D, Fortea J, Lleó A, Cortés E, Rojas R. Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2):e200072. DOI:10.1212/NXI.0000000000200072. PMID:36460480. IF:8,300 (Q1/1D). Document type: Article.
-Del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok YS, Lleó A, Alcolea D, van M, Engelborghs S, van JL, Arezoumandan S, Chen A, Irwin DJ, van der Flier WM, Lemstra AW, Teunissen CE. CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease. Nature Communications. 2023; 14(1):5635. DOI:10.1038/s41467-023-41122-y. PMID:37704597. IF:14,700 (Q1/1D). Document type: Article.
-Dou J, Bakulski K, Guo K, Hur J, Zhao L, Saez S, Stark A, Chia R, García A, Rojas R, Vázquez JF, Fernandez R, Bandres S, Gómez P, Periñán MT, Mir P, Pérez J, Cardona F, Menendez M, Riancho J, Borrego D, Galán L, Infante J, Pastor P, Paradas C, Dols O, Traynor BJ, Feldman EL, Goutman SA, Spanish C. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies. Neurology-Genetics. 2023; 9(4):e200079. DOI:10.1212/NXG.0000000000200079. PMID:37293291. IF:3,600 (Q1/3D). Document type: Article.
-Ferrer P, Puertollano D, Querol M, Sánchez É, Valle N, Cervantes A, Nuñez R, Pegueroles J, Dols O, Iulita MF, Aldecoa I, Molina L, Sánchez R, Fortea J, Belbin O, Sirisi S, Lleó A. Amyloid precursor protein ßCTF accumulates in synapses in sporadic and genetic forms of Alzheimer’s disease. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2023; 49(1):e12879. DOI:10.1111/nan.12879. PMID:36702749. IF:4,000 (Q1/2D). Document type: Article.
-Fitri FI, Lage C, Mollayeva T, Santamaria H, Chan MLS, Cominetti MR, Daria T, Fallon G, Gately D, Gichu M, Gimenez S, Zuniga RG, Hadad R, Hill T, O’Kelly M, Martinez L, Modjaji P, Ngcobo N, Nowak R, Ogbuagu C, Roche M, Aguzzoli CS, Shin SY, Smith E, Yoseph SA, Zewde Y, Ayhan Y. Empathy as a crucial skill in disrupting disparities in global brain health. Frontiers in Neurology. 2023; 14:1189143. DOI:10.3389/fneur.2023.1189143. PMID:38162446. IF:2,700 (Q2/4D). Document type: Article.
-Fortea J, Garcia E, Garcia G, Canal N, Maurino J. Burnout among neurologists caring for patients with cognitive disorders in Spain. PLoS One. 2023; 18(5):e0286129. DOI:10.1371/journal.pone.0286129. PMID:37228146. IF:2,900 (Q1/3D). Document type: Article.
-Fortea J, Garcia E, Terrancle A, Galvez B, Diez V, Rebollo P, Maurino J, Garcia G. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer’s Disease. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(1). DOI:10.3233/JAD-221160. PMID:36970902. IF:3,400 (Q2/4D). Document type: Article.
-Fortea J, Quiroz YT, Ryan NS. Lessons from Down syndrome and autosomal dominant Alzheimer’s disease. LANCET NEUROLOGY. 2023; 22(1). DOI:10.1016/S1474-4422(22)00437-9. PMID:36517171. IF:46,500 (Q1/1D). Document type: Editorial Material.
-Franzen S, Nuytemans K, Bourdage R, Caramelli P, Ellajosyula R, Finger E, Illan I, Loi SM, Morhardt D, Pijnenburg Y, Rascovsky K, Williams MM, Yokoyama JS, Alladi S, Ayhan Y, Broce I, Castro S, Coleman K, de Souza LC, Dacks PA, de Boer SCM, de Leon J, Dodge S, Grasso S, Gupta V, Gupta V, Ghoshal N, Kamath V, Kumfor F, Matias JA, Narme P, Nielsen TR, Okhuevbie D, Pina SD, Garcia RR, Scarioni M, Slachevsky A, Suarez A, Tee BL, Tsoy E, Ulugut H, Babulal GM, Onyike CU, ISTAART FTD, ISTAART Diversity Disparities P. zZ Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused research. Alzheimers & Dementia. 2023. DOI:10.1002/alz.13129. PMID:37270665. IF:13,000 (Q1/1D). Document type: Article.
-Friedberg A, Pasquini L, Diggs R, Glaubitz EA, Lopez L, Illán I, Iaccarino L, La Joie R, Mundada N, Knudtson M, Neylan K, Brown J, Allen IE, Rankin KP, Bonham LW, Yokoyama JS, Ramos EM, Geschwind DH, Spina S, Grinberg LT, Miller ZA, Kramer JH, Rosen H, Gorno ML, Rabinovici G, Seeley WW, Miller BL. Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal Dementia. JAMA Neurology. 2023; 80(4). DOI:10.1001/jamaneurol.2023.0001. PMID:36848111. IF:20,400 (Q1/1D). Document type: Article.
-Gagliardi G, Rodriguez E, Montal V, Sepulcre J, Diez I, Lois C, Hanseeuw B, Schultz AP, Properzi MJ, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini P. Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. Communications Medicine. 2023; 3(1):106. DOI:10.1038/s43856-023-00324-7. PMID:37528163. IF:5,400 (Q1/2D). Document type: Article.
-Gasca C, Trompeta C, López M, Rodríguez R, Clarimon J, Dols O, El Bounasri S, Guida P, Mata D, Hernández F, Marras C, García L, Plaza de Las Heras I, Obeso I, Vela L, Fernández B. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson’s disease. JOURNAL OF NEUROIMAGING. 2023; 33(6). DOI:10.1111/jon.13156. PMID:37726927. IF:2,300 (Q2/5D). Document type: Article.
-Giménez S, Tapia IE, Fortea J, Levedowski D, Osorio R, Hendrix J, Hillerstrom H. Caregiver knowledge of obstructive sleep apnoea in Down syndrome. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH. 2023; 67(1). DOI:10.1111/jir.12990. PMID:36416001. IF:2,100 (Q1/2D). Document type: Article.
-Gonzalez MC, Tovar DA, Alves G, Dalen I, Williams CH, Camacho M, Forsgren L, Backstrom D, Lawson RA, Macleod AD, Counsell CE, Paquet C, DeLena C, D’Antonio F, Pilotto A, Padovani A, Blanc F, Falup C, Lewis SJG, Rejdak K, Papuc E, Hort J, Nedelska Z, O’Brien J, Bonanni L, Marquie M, Boada M, Pytel V, Abdelnour C, Alcolea D, Beyer K, Tysnes OB, Aarsland D, Maple J. Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson’s Disease Dementia. Movement Disorders Clinical Practice. 2023; 10(6). DOI:10.1002/mdc3.13752. PMID:37332651. IF:2,600 (Q2/5D). Document type: Article.
-Goossens J, González AC, Dewit N, Lidón L, Fortea J, Alcolea D, Lleó A, Belbin O, Vanmechelen E. Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum. Alzheimers Research & Therapy. 2023; 15(1):186. DOI:10.1186/s13195-023-01336-0. PMID:37898760. IF:8,000 (Q1/1D). Document type: Article.
-Grasso SM, Rodríguez C, Colomer NM, Kiderle SKM, Sáanchez R, Santos M. Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices. JOURNAL OF ALZHEIMERS DISEASE. 2023; 96(4). DOI:10.3233/JAD-230673. PMID:37980666. IF:3,400 (Q2/4D). Document type: Review.
-Guillén N, Contador J, Buongiorno M, Alvarez I, Culell N, Alcolea D, Lleó A, Fortea J, Piñol G, Carnes A, Ispierto ML, Vilas D, Puig A, Fernández A, Balasa M, Sánchez R, Lladó A. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2023; DOI:10.1007/s00406-023-01701-y. PMID:37898567. IF:3,500 (Q1/3D). Document type: Article.
-Hamlett ED,Flores L,Handen B,Potier M-C,Granholm A-C,Sherman S,Puig V et al. Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society. ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND:KARGER. 2023. p.p. 89-100. Document type: Conference Paper.
-Hirschberg Y, Valle N, Dols O, Engelborghs S, Buelens B, Vandenbroucke RE, Vermeiren Y, Boonen K, Mertens I. Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 2023; 12(12):e12383. DOI:10.1002/jev2.12383. PMID:38082559. IF:15,500 (Q1/1D). Document type: Article.
-Hok YS, Bolsewig K, Ruiters DN, Lleo A, Alcolea D, Lemstra AW, van der Flier WM, Teunissen CE, del Campo M. Thimet oligopeptidase as a potential CSF biomarker for Alzheimer’s disease: A cross-platform validation study. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2023; 15(3):e12456. DOI:10.1002/dad2.12456. PMID:37502019. IF:4,000 (Q1/2D). Document type: Article.
-Iulita MF, Bejanin A, Vilaplana E, Carmona M, Benejam B, Videla L, Barroeta I, Fernández S, Altuna M, Pegueroles J, Montal V, Valldeneu S, Gimenez S, González S, Torres S, El Bennadi SE, Padilla C, Aranha MR, Estelles T, Illán I, Belbin O, Valle N, Camacho V, Blessing E, Osorio RS, Videla S, Lehmann S, Holland AJ, Zetterberg H, Blennow K, Alcolea D, Clarimón J, Zaman SH, Blesa R, Lleó A, Fortea J. Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome. Brain Communications. 2023; 5(2):fcad074. DOI:10.1093/braincomms/fcad074. PMID:37056479. IF:4,100 (Q1/2D). Document type: Article.
-Lorca DL, Gajardo A, Mandelli ML, Illán I, Ezzes Z, Wauters LD, Battistella G, Bogley R, Ratnasiri B, Licata AE, Battista P, García AM, Tee BL, Lukic S, Boxer AL, Rosen HJ, Seeley WW, Grinberg LT, Spina S, Miller BL, Miller ZA, Henry ML, Dronkers NF, Gorno ML. Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum. BRAIN. 2023; DOI:10.1093/brain/awad327. PMID:37769652. IF:11,900 (Q1/1D). Document type: Article.
-Mansilla A, Canyelles M, Ferrer R, Arranz J, Rodriguez I, Zhu N, Rubio S, El Bounasri S, Sanchez O, Torres S, Fortea J, Lleo A, Alcolea D, Tondo M. Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer’s disease. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 61(9). DOI:10.1515/cclm-2023-0245. PMID:37083158. IF:3,800 (Q1/2D). Document type: Article.
-McGlinchey E, Iulita MF, Fortea J. Compounded inequality: racial disparity and Down syndrome. Lancet Public Health. 2023; 8(11). DOI:10.1016/S2468-2667(23)00213-X. IF:25,400 (Q1/1D). Document type: Letter.
-Montoliu L, Alcolea D, Ashton NJ, Pegueroles J, Levin J, Bosch B, Lantero J, Carmona M, Wagemann O, Balasa M, Kac PR, Barroeta I, Llado A, Brum WS, Videla L, Gonzalez F, Benejam B, Martinez J, Karikari TK, Nubling G, Bejanin A, Benedet AL, Blesa R, Lleo A, Blennow K, Sanchez R, Zetterberg H, Fortea J. Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study. EBioMedicine. 2023; 90:104547. DOI:10.1016/j.ebiom.2023.104547. PMID:37002988. IF:9,700 (Q1/1D). Document type: Article.
-Mulet L, Solé C, Cabello M, Abellaneda K, Perellón R, Cattaneo G, Solana J, Alviarez V, Bargalló N, Tormos JM, Pascual A, Bartrés D, Vaqué L. Brain connectivity correlates of cognitive dispersion in a healthy middle-aged population: influence of subjective cognitive complaints. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES. 2023; 78(11). DOI:10.1093/geronb/gbad114. PMID:37587033. IF:4,800 (Q1/1D). Document type: Article.
-Neumann A, Ohlei O, Küçükali F, Bos IJ, Timsina J, Vos S, Prokopenko D, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Scheltens P, Teunissen CE, Engelborghs S, Frisoni GB, Blin O, Richardson JC, Bordet R, Lleó A, Alcolea D, Popp J, Marsh TW, Gorijala P, Clark C, Peyratout G, Martinez P, Tainta M, Dobson RJB, Legido C, Van C, Tanzi RE, Ten M, Lill CM, Barkhof F, Cruchaga C, Lovestone S, Streffer J, Zetterberg H, Visser PJ, Sleegers K, Bertram L, EMIF &. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning. Genome Medicine. 2023; 15(1):79. DOI:10.1186/s13073-023-01233-z. PMID:37794492. IF:10,400 (Q1/1D). Document type: Article.
-Olazarán J, Carnero C, Fortea J, Sánchez P, García G, Vinuela F, Martínez P, Boada M. Prevalence of treated patients with Alzheimer’s disease: current trends and COVID-19 impact. Alzheimers Research & Therapy. 2023; 15(1):130. DOI:10.1186/s13195-023-01271-0. PMID:37537656. IF:8,000 (Q1/1D). Document type: Article.
-Rafii MS, Fortea J. Down Syndrome in a New Era for Alzheimer Disease. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2023; 330(22). DOI:10.1001/jama.2023.22924. PMID:37991807. IF:63,100 (Q1/1D). Document type: Article.
-Shi L, Xu J, Green R, Wretlind A, Homann J, Buckley NJ, Tijms BM, Vos SJB, Lill CM, Kate MT, Engelborghs S, Sleegers K, Frisoni GB, Wallin A, Lleó A, Popp J, Martinez P, Streffer J, Barkhof F, Zetterberg H, Visser PJ, Lovestone S, Bertram L, Nevado AJ, Proitsi P, Legido C. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer’s disease. Alzheimers & Dementia. 2023; 19(8). DOI:10.1002/alz.12961. PMID:36790009. IF:13,000 (Q1/1D). Document type: Article.
-Trifunov S, Natera D, Carrera L, Codina A, Expósito J, Ortez C, Medina J, Alcala ST, Bernal S, Alias L, Badosa C, Balsells S, Alcolea D, Nascimento A, Jimenez C. Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen. Journal Of Neuromuscular Diseases. 2023; 10(4). DOI:10.3233/JND-230012. PMID:37038823. IF:3,200 (Q2/3D). Document type: Article.
-Videla L, Benejam B, Carmona M, Barroeta I, Fernández S, Arranz J, Azzahchi SE, Altuna M, Padilla C, Valldeneu S, Pegueroles J, Montal V, Aranha MR, Vaqué L, Iulita MF, Alcolea D, Bejanin A, Videla S, Blesa R, Lleó A, Fortea J. Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer’s disease in adults with Down syndrome. Alzheimers & Dementia. 2023; 19(9). DOI:10.1002/alz.13073. PMID:37038748. IF:13,000 (Q1/1D). Document type: Article.
-Villarejo A, García E, Piñol G, del Olmo A, Viñuela F, Boada M, Franco E, de la Peña AI, Riverol M, Puig A, Abizanda P, Arroyo R, Baquero M, Feria I, Balasa M, Berbel A, Rodríguez E, Vieira A, Garcia G, Rodrigo S, Lleó A, Maurino J. Medical help-seeking intentions among patients with early Alzheimer’s disease. Frontiers in Psychiatry. 2023; 14:1290002. DOI:10.3389/fpsyt.2023.1290002. PMID:38173708. IF:3,200 (Q2/4D). Document type: Article.
(JIF 2022)